Scientific Advisory Board Announcement

The Myrovlytis Trust is delighted to announce the formation of its Scientific Advisory Board. The Board will be comprised, initially, of Eamonn Maher MD FRCP FMedSci, Professor of Medical Genetics at Birmingham University, UK, and Laura Schmidt PhD, staff scientist at the National Cancer Institute-Frederick, NIH, USA. The Board will “advise the Trust regarding its scientific direction and focus”.